Mfazo Hove, MD, FRCOphth, a consultant ophthalmologist based in London, has a personal perspective on the trifocal ...
Artificial intelligence (AI) is set to reshape multiple corners of eye care, according to Jai Parekh, MD, MA, FAAO, who ...
Radhika Rampat, MBBS, FRCOphth, discusses how AI is already shaping intraocular lens selection and keratoconus screening, and ...
Mingo Botín, MD, PhD, discusses ESCRS 2026 data on an EDOF IOL in post-LASIK eyes vs non-LASIK controls.
Beyond the Walls: Risks, reinvention, and redefining the patient experience with Alison D. Early, MD
In this latest episode of the Ophthalmology Times® “Beyond the Walls” podcast, host Deborah Ristvedt, DO, sits down with Alison D. Early, MD, a cataract and refractive surgeo ...
At the 44th Congress of the ESCRS in London, Mark Bullimore, PhD, MCOptom, said delaying myopia onset is more valuable than slowing its progression, and explained how to identify children most at risk ...
Atrial fibrillation appears to cause thinning of the macular ganglion cell and inner plexiform layer. Long before doctors ...
The US Food and Drug Administration (FDA) recently accepted Nanoscope Therapeutics’ biologics license application (BLA) for ...
Two-year data presented at ESCRS 2026 show the ELIOS excimer laser procedure sustained IOP reduction and kept most glaucoma ...
At ESCRS 2026, Zoltan Z. Nagy, MD, reported that femtosecond laser trabeculotomy (FLigHT) cut intraocular pressure by 27% at 48 months in open-angle glaucoma, with a stable, incision-free safety ...
Majda Hadziahmetovic, MD: MacTel type 2 is a slowly progressive disease. The hallmark of the disease is chronic neurodegeneration of the outer retina, including Müller cell dysfunction, photoreceptor ...
ESCRS 2026 real-world data: aceclidine (VIZZ; LENZ Therapeutics) drops show fast onset, high satisfaction for presbyopia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results